Sector: MedicalGENTIUM SPA ADS (NASDAQ: GENT)
Headlines
- Gentium Announces Presentation of Defibrotide Clinical Data at the American Society of Hematology Annual Meeting
Nov 16, 2009 07:30 AM | GENT
- Gentium Announces New Board of Directors and Interim CEO
Nov 09, 2009 07:30 AM | BLUS, GENT, TAP
- Gentium Reports Top Line Results from the Phase III Treatment Trial of Defibrotide for Severe Veno-Occlusive Disease
Aug 19, 2009 07:30 AM | GENT
- 11 Hot Stocks To Short & Mark Cuban Getting Caught For Insider Trading On Copernic Inc. (CNIC)
Nov 17, 2008 01:29 PM | DFT, FUQI, GENT
- Unemployment Rate 5.5%
Jun 06, 2008 12:37 PM | AAUK, ACLS, ASMI, BUCY, CALM, CFC
- Italy’s New Prime Minister Could Bring “La Dolce Vita” to Investors
Apr 22, 2008 12:55 AM | E, GENT, LUX, NTZ, TI
- Gentium Reports Second Quarter Financial Results; Provides Financial and Clinical Update
Sep 17, 2009 07:52 AM | GENT
- Gentium Announces Director Resignations and Other Governance Changes
Aug 06, 2009 07:33 AM | GENT
- Gentium Reports First Quarter Financial Results; Provides Financial and Clinical Update
Jun 04, 2009 04:54 PM | GENT
- Gentium Reports 2008 Financial Results; Provides Financial Update
Mar 31, 2009 04:05 PM | GENT
- Gentium Announces Preliminary Results from a Phase 2/3 European Pediatric Prevention Trial for Veno-Occlusive Disease at the European Group for Blood and Marrow Transplantation Annual Meeting
Mar 29, 2009 03:21 AM | GENT
- Gentium Reports Third Quarter Financial Results; Provides Financial Update
Mar 10, 2009 04:31 PM | GENT
- Gentium Announces Completion of Enrollment for the Phase II/III European Pediatric Prevention Trial of Defibrotide
Jan 22, 2009 07:31 AM | GENT
- Gentium Reports Second Quarter Financial Results; Provides Phase II/III Pediatric Prevention Trial and Financial Update
Dec 17, 2008 04:01 PM | GENT
- Gentium Provides an Update on the Phase 3 Treatment Trial of
Defibrotide for Severe Veno-Occlusive Disease
Nov 19, 2008 04:02 PM | GENT
- Gentium Announces that Italian Court Rejects Plaintiffs' Claims and Ends Legal Proceeding
Oct 02, 2008 07:46 AM | GENT
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
GENT
|
Compare to S&P
|
| YTD |
249.15 %
|
188.97 %
|
| 4 Weeks |
-15.92 %
|
-16.83 %
|
| 12 Weeks |
-43.09 %
|
-46.35 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -69.23 %
|
|
EPS Growth in Last Year: 6.38 %
|
|
Sales Growth in Last Quarter: 103.49 %
|
|
Sales Growth in Last Quarter: -6.04 %
|
|
